Report cover image

Dog Vaccines Market Growth, Size, Trends Analysis - By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jan 08, 2025
Length 246 Pages
SKU # SPER19520454

Description

Dog Vaccines Market Growth, Size, Trends Analysis - By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034


Dog Vaccines Market Introduction and Overview

According to SPER market research, ‘Global Dog Vaccines Market Size- By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Distribution Channel – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Global Dog Vaccines Market is predicted to reach 3.79 billion by 2034 with a CAGR of 6.68%.

Vaccines help prepare a dog’s immune system to defend against any invasion of pathogenic organisms. Antigens in vaccines mimic disease-causing organisms in the dog’s immune system without actually causing illness. The market for dog vaccines is expanding quickly, which is explained by the fact that puppy and dog vaccines work to gradually boost immunity by detecting the presence of antigens. In this way, if a dog develops a predisposition to the disease.

Restraints: The market’s expansion is hampered by factors including strict regulations, the high expense of developing vaccines, and the requirement for cold chain logistics to guarantee vaccine effectiveness. Further impeding expansion is the occasional immunization hesitation among pet owners brought on by false information or worries about unpleasant reactions.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Distribution Channel

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Boehringer Ingelheim International GmbH, Zoetis Services LLC, Merck & Co., Inc, Elanco, Hester Biosciences Limited, Virbac, Bioveta a.s, Brilliant Bio Pharma, Heska Corporation, Zendal Group.

Dog Vaccines Market Segmentation:

By Vaccine Type: Based on the Vaccine Type, Global Dog Vaccines Market is segmented as; Modified/ Attenuated Live, Inactivated, Other Vaccines.

By Disease Type: Based on the Disease Type, Global Dog Vaccines Market is segmented as; Canine Distemper, Canine Infectious Respiratory Disease Complex, Canine Parvovirosis/ Parvovirus Disease, Canine Leptospirosis, Canine Lyme Disease, Infectious Canine Hepatitis, Canine Rabies, Other Diseases.

By Route of Administration: Based on the Route of Administration, Global Dog Vaccines Market is segmented as; Injectables, Intranasal, Oral.

By Duration of Immunity: Based on the Duration of Immunity, Global Dog Vaccines Market is segmented as; 1 Year, 3 Year, Others.

By Component: Based on the Component, Global Dog Vaccines Market is segmented as; Combined Vaccines, Mono Vaccines.

Table of Contents

246 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Dog Vaccines Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Dog Vaccines Market
7. Global Dog Vaccines Market, By Vaccine Type (USD Million) 2021-2034
7.1. Modified/ Attenuated Live
7.2. Inactivated (Killed)
7.3. Other Vaccines
8. Global Dog Vaccines Market, By Disease Type (USD Million) 2021-2034
8.1. Canine Distemper
8.2. Canine Infectious Respiratory Disease Complex (CIRDC)
8.3. Canine Parvovirosis/ Parvovirus Disease
8.4. Canine Leptospirosis
8.5. Canine Lyme Disease
8.6. Infectious Canine Hepatitis
8.7. Canine Rabies
8.8. Other Diseases
9. Global Dog Vaccines Market, By Route of Administration (USD Million) 2021-2034
9.1. Injectables
9.2. Intranasal
9.3. Oral
10. Global Dog Vaccines Market, By Duration of Immunity (USD Million) 2021-2034
10.1. 1 Year
10.2. 3 Year
10.3. Others
11. Global Dog Vaccines Market, By Component (USD Million) 2021-2034
11.1. Combined Vaccines
11.2. Mono Vaccines
12. Global Dog Vaccines Market, By Distribution Channel (USD Million) 2021-2034
12.1. Retail
12.2. E-Commerce
12.3. Hospital/Clinic Pharmacies
13. Global Dog Vaccines Market (USD Million) 2021-2034
13.1. Global Dog Vaccines Market Size and Market Share
14. Global Dog Vaccines Market, By Region (USD Million) 2021-2034
14.1. Asia-Pacific
14.1.1. Australia
14.1.2. China
14.1.3. India
14.1.4. Japan
14.1.5. South Korea
14.1.6. Rest of Asia-Pacific
14.2. Europe
14.2.1. France
14.2.2. Germany
14.2.3. Italy
14.2.4. Spain
14.2.5. United Kingdom
14.2.6. Rest of Europe
14.3. Middle East and Africa
14.3.1. Kingdom of Saudi Arabia
14.3.2. United Arab Emirates
14.3.3. Qatar
14.3.4. South Africa
14.3.5. Egypt
14.3.6. Morocco
14.3.7. Nigeria
14.3.8. Rest of Middle-East and Africa
14.4. North America
14.4.1. Canada
14.4.2. Mexico
14.4.3. United States
14.5. Latin America
14.5.1. Argentina
14.5.2. Brazil
14.5.3. Rest of Latin America
15. Company Profile
15.1. Zoetis
15.1.1. Company details
15.1.2. Financial outlook
15.1.3. Product summary
15.1.4. Recent developments
15.2. Boehringer Ingelheim International GmbH
15.2.1. Company details
15.2.2. Financial outlook
15.2.3. Product summary
15.2.4. Recent developments
15.3. Merck & Co., Inc
15.3.1. Company details
15.3.2. Financial outlook
15.3.3. Product summary
15.3.4. Recent developments
15.4. Elanco
15.4.1. Company details
15.4.2. Financial outlook
15.4.3. Product summary
15.4.4. Recent developments
15.5. Virbac
15.5.1. Company details
15.5.2. Financial outlook
15.5.3. Product summary
15.5.4. Recent developments
15.6. Bioveta a.s
15.6.1. Company details
15.6.2. Financial outlook
15.6.3. Product summary
15.6.4. Recent developments
15.7. Hester Biosciences Limited
15.7.1. Company details
15.7.2. Financial outlook
15.7.3. Product summary
15.7.4. Recent developments
15.8. Brilliant Bio Pharma
15.8.1. Company details
15.8.2. Financial outlook
15.8.3. Product summary
15.8.4. Recent developments
15.9. Heska Corporation
15.9.1. Company details
15.9.2. Financial outlook
15.9.3. Product summary
15.9.4. Recent developments
15.10. Zendal Group
15.10.1. Company details
15.10.2. Financial outlook
15.10.3. Product summary
15.10.4. Recent developments
15.11. Others
16. Conclusion
17. List of Abbreviations
18. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us